Clinical Trial Update: A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2, single-arm trial evaluating fruquintinib plus envafolimab in advanced or unresectable locally advanced bone and soft tissue sarcoma is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone and Soft Tissue Sarcoma

Drugs mentioned

• Envafolimab (envafolimab)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Shanghai 6th People's Hospital | Conditions: Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma | Phase 2 | Status: RECRUITING